Search

everythinglearnresearchcommunity

for

Search:↓

A new method effectively predicts estrogen-related health effects for early screening.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Robotic technology greatly improves cosmetic dermatology outcomes and patient satisfaction.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Alopecia areata affects about 2% of people and can impact any hair area.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

Early intervention in patch-type alopecia may prevent progression to more severe forms by targeting immune pathways and preserving keratin.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

Alopecia areata causes significant emotional and social challenges, especially with more hair loss.

The combined treatment for hair loss is effective, easy to use, and has mild side effects.

More personalized and effective treatments for androgenetic alopecia are needed.

Alopecia areata and its severe forms are becoming more common, especially among females, adults, and people in the Northeast.

Higher air pollution increases the risk of alopecia areata.

iEdgePathDDA effectively finds new drug-disease links, outperforming other methods.

New imaging technology can show up to 40 different markers in hair loss tissue, helping to understand hair disease better.

New methods reliably assess hair regrowth and scalp health in hair loss patients.

Measuring bald patch size can help grade hair loss severity, with photograph-based evaluation being more reliable.

Different hair transplant tools work best in different situations; surgeons should know their tools and patient differences to improve results.

Alopecia areata causes negative emotions and stress due to hair loss and emotional triggers.

A new teledermatology system improved access and reduced wait times for skin care.

Hair loss from alopecia areata and androgenetic alopecia moderately affects the quality of life, especially in younger patients and those with long-term hair loss, impacting both their physical and emotional well-being.

The C-CAT tool helps assess and improve treatment for central centrifugal cicatricial alopecia.

The combination of PRP and triamcinolone injections improved hair growth in a man with alopecia areata.

Standardized PRP therapy can improve treatment for hair loss.

Hair specialists vary in testing for alopecia areata, highlighting the need for standard guidelines.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Wigs greatly improve life quality for hair loss patients.